KUALA LUMPUR — Modern radiology is moving beyond image capture to directly drive clinical decision-making and patient outcomes, experts emphasized at the Malaysian Congress of Radiology (MCOR) 2026.

Held under the theme “Image. Inform. Impact: Radiology’s Expanding Role in Oncology,” this year’s congress gathered medical imaging professionals to examine how diagnostic advancements and molecular imaging are reshaping the cancer care pathway.

Delivering an opening address and presenting on advanced imaging, Dr Farhana Fadzli outlined the evolving definition of the specialty's clinical value.

“We image, but today, producing and interpreting images is only the beginning,” said Dr Farhana. “We inform, because our interpretation increasingly helps determine what happens next, whether a patient needs a biopsy, surgery, systemic therapy, radiotherapy, intervention, further molecular imaging, or sometimes simply reassurance. And ultimately, we must impact, because the true value of radiology is not measured by the number of examinations we perform or reports we produce, but by how we influence patient care and outcomes.”

Advancing Molecular Imaging in Prostate Cancer

In her presentation, titled “PSMA PET: Changing the Prostate Cancer Pathway,” Dr Farhana highlighted prostate-specific membrane antigen (PSMA) PET imaging as a prime example of radiology's evolving clinical weight. The molecular imaging technique provides clearer staging, sharper diagnostic accuracy, and enables clinicians to tailor personalized therapies for prostate cancer patients.

Addressing the broader identity of the profession, Dr Farhana noted that while radiologists often work behind the scenes without the visibility afforded to other specialties, the clinical data and insights they generate fundamentally dictate the trajectory of patient management.

She added that addressing complex challenges in oncology requires interdisciplinary synergy: “The challenges in cancer care are too significant for any one specialty to address alone, and collaboration, innovation and clinical excellence will remain essential.”

Strengthening Regional Ties

Beyond clinical developments, MCOR 2026 served as a platform for regional cooperation, highlighting a new partnership between the radiology communities of Malaysia and Thailand. The initiative aims to enhance oncological imaging standards across Southeast Asia through joint research, clinical knowledge exchange, and shared professional expertise.

Dr Farhana concluded that technological evolution must stay grounded in patient-centric outcomes: “The future is not simply about having better technology. It is about continually pushing the boundaries of what is possible and ensuring that innovation translates into better care for our patients.”


Credits: Information and visual assets sourced from Dr. Farhana Fadzli (LinkedIn) and the official Malaysian Congress of Radiology (MCOR) page.